BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

miRagen Therapeutics 

6200 Lookout Road
Suite 100
Boulder  Colorado  80301  U.S.A.
Phone: 303-531-5952 Fax: 303-531-5094


SEARCH JOBS





Segment
Start Up





 Company News
miRagen Therapeutics Expands Executive Leadership Team Adding Drug Development Veteran 3/25/2014 7:30:07 AM    More...
miRagen Therapeutics Adds Biotech and Pharmaceutical Industry Veterans to Senior Leadership Team 6/11/2013 6:55:59 AM    More...
miRagen Therapeutics Achieves First Milestone in Strategic Alliance With Servier 5/23/2013 10:59:42 AM    More...
miRagen Therapeutics Exclusively Licenses Intellectual Property From the University of Glasgow for microRNA-145 Targeting in the Treatment of Pulmonary Arterial Hypertension 3/5/2013 9:44:01 AM    More...
Santaris Pharma A/S and miRagen Therapeutics Expand Worldwide Strategic Alliance to Discover and Develop LNA-Drugs Against Disease Causing Micrornas 1/8/2013 9:56:12 AM    More...
miRagen Therapeutics Named to FierceBiotech’s 2012 Fierce 15 List of Most Promising Private Biotechnology Companies 9/19/2012 9:52:39 AM    More...
miRagen Therapeutics Announces the Publication of Compelling Data Suggesting the MIRG-9103 Program May Have Utility in Treating Multiple Disorders Associated with Metabolic Syndrome 4/26/2012 10:55:35 AM    More...
miRagen Therapeutics Expands Executive Team Adding Drug Development Veteran 4/24/2012 10:25:39 AM    More...
miRagen Therapeutics Secures $20 Million Series B Financing 4/24/2012 7:08:03 AM    More...
Silence Therapeutics plc Signs Collaboration with miRagen Therapeutics to Evaluate Delivery of Novel microRNA-based Therapeutics 1/9/2012 10:34:16 AM    More...
1234